Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Oct;7(4):495-507.
doi: 10.1215/S1152851705000037.

ERCC1 and ERCC2 polymorphisms and adult glioma

Margaret Wrensch  1 , Karl T Kelsey, Mei Liu, Rei Miike, Michelle Moghadassi, Jennette D Sison, Kenneth Aldape, Alex McMillan, Joseph Wiemels, John K Wiencke
Affiliations
Comparative Study

ERCC1 and ERCC2 polymorphisms and adult glioma

Margaret Wrensch et al. Neuro Oncol. 2005 Oct.

Abstract

ERCC2 and ERCC1 are important in DNA nucleotide excision repair and lie on chromosome 19q13.3 near a putative glioma suppressor region. We genotyped constitutive variants ERCC1 C8092A and ERCC2 K751Q and R156R in approximately 450 adults with glioma and 500 controls from two independent population-based series, uniformly reviewed patients' tumors to determine histopathologic category, and determined a variety of tumor markers among astrocytic tumors. Odds ratios (ORs) for glioblastoma for those carrying two ERCC1 A alleles versus none or one were 1.67 in series 1 and 1.64 in series 2, which yielded a combined OR of 1.67 (95% CI, 0.93-3.02; P = 0.09), adjusted for age, gender, ethnicity, and series. Odds ratios for the ERCC2 variants were not consistently elevated or reduced for the two series in all cases versus controls. However, among whites, for those with ERCC2 K751Q genotype QQ versus QK/KK, the OR for nonglioblastoma histologies versus controls was 1.82 (95% CI, 0.97-3.44; P = 0.06). Also, among whites, glioma patients were significantly more likely than controls to be homozygous for variants in both ERCC1 C8092A and ERCC2 K751Q (OR, 3.2; 95% CI, 1.1-9.3). Given the numbers of comparisons made, these findings could be due to chance. However, the results might warrant clarification in additional series in conjunction with the nearby putative glioma suppressor genes (GLTSCR1 and GLTSCR2).

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Affatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammenheuser MM, Abdel-Rahman SZ. Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ Mol Mutagen. 2004;44:65–73. - PubMed
    1. Aiub CA, Mazzei JL, Pinto LF, Felzenszwalb I. Participation of BER and NER pathways in the repair of DNA lesions induced at low N-nitrosodiethylamine concentrations. Toxicol Lett. 2004;154:133–142. - PubMed
    1. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002;17:463–469. - PubMed
    1. Blumberg, S.J., Luke, J.V., and Cynamon, M.L. (2004) Has cord-cutting cut into random-digit-dialed health surveys? The prevalence and impact of wireless substitution. In: Cohen, S.B., and Lepkowski, J.M. (Eds.), Eighth Conference on Health Survey Research Methods Hyattsville, Md.: National Center for Health Statistics.
    1. Boiteux S, Gellon L, Guibourt N. Repair of 8-oxoguanine in Saccharomyces cerevisiae: Interplay of DNA repair and replication mechanisms. Free Radic Biol Med. 2002;32:1244–1253. - PubMed

Publication types